Enoxaparin is a type of blood thinner. It helps prevent blood clots from forming in your veins, which can cause serious problems like stroke or heart attack. It's often used to prevent clots after surgery or for people with certain heart conditions.
Every report comes from a Lived member, sent anonymously.
Have you tried Lovenox (Enoxaparin) for DVT (Deep Vein Thrombosis)?
Enoxaparin, sold under the brand name Lovenox and as generic enoxaparin, is an injectable blood thinner (anticoagulant) used to prevent and treat blood clots. It belongs to a group of medicines called low molecular weight heparins, which are refined versions of heparin, an older blood thinner given in hospitals. Its most familiar use is preventing deep vein thrombosis (DVT), a clot in a deep vein, usually in the leg, that can break loose and travel to the lungs as a pulmonary embolism. In the US it is approved to prevent DVT after abdominal surgery and hip or knee replacement, and in people whose mobility is severely limited during a hospital stay for an acute illness. It is also approved to treat an existing DVT, including in hospital when a clot has reached the lungs, often as a bridge while an oral blood thinner such as warfarin takes effect. In hospital, enoxaparin is also given alongside aspirin to people with unstable angina (chest pain from a heart artery that is newly narrowing) or certain types of heart attack, to lower the chance of further clotting in the heart arteries. It is also widely used during pregnancy, since guidelines favor low molecular weight heparins for treating clots in pregnant people.
Blood clots form through a chain of clotting proteins, each switching on the next. The body keeps this chain in check with antithrombin, a natural protein that turns off several of these clotting proteins. Enoxaparin attaches to antithrombin and makes it work much faster, especially against factor Xa, one of the key proteins near the end of the chain, and to a lesser extent against thrombin. With less of these proteins active, new clots are less likely to form and existing clots are less likely to grow. Enoxaparin does not dissolve a clot that is already there; the body breaks that down gradually on its own. Compared with standard heparin, enoxaparin's smaller molecules behave more predictably in the body and last longer. That is why it can be given as an injection under the skin once or twice a day without the frequent blood tests heparin usually needs.
Enoxaparin comes mainly in single-use prefilled syringes, plus multiple-dose vials used largely in hospitals. It is injected under the skin (subcutaneously), usually into the fatty tissue of the belly, and is never injected into a muscle. In hospital it is sometimes also given into a vein. The dose depends on the reason for treatment. Preventing clots typically uses a fixed dose once or twice a day, while treating an existing clot uses a larger dose based on body weight, given every 12 hours or once a day. Doses are usually lowered when kidney function is severely reduced. Prevention after surgery or a hospital stay often lasts about one to three weeks; treatment of a clot continues until another blood thinner takes over or for as long as the care team advises. Many people learn to inject themselves, or have a caregiver do it, after training from a nurse or pharmacist. A few points matter for the prefilled syringe: do not push out the small air bubble before injecting, because that wastes some of the dose; pinch a fold of skin and insert the whole needle; switch sides of the belly with each injection; and do not rub the spot afterward, which makes bruising worse. Enoxaparin cannot be swapped unit for unit with heparin or other low molecular weight heparins, so a product change needs a new prescription. If a dose is missed, follow the care team's instructions and do not double up.
Bruising or soreness where the injection goes in are very common, especially when injections are given every day. Bleeding more easily is the main effect of any blood thinner: cuts may take longer to stop, and gums or the nose may bleed more than usual. Other reported effects include nausea, diarrhea, fever, swelling and changes in blood tests such as a lower blood count or raised liver enzymes. Contact the care team right away for bleeding that is unusual or hard to stop, black or bloody stools, blood in the urine, or a rash of tiny dark red spots under the skin, which can signal a low platelet count. A serious fall or blow to the head needs prompt medical assessment even if you feel fine, because bleeding inside the skull may not cause symptoms at first. Rarely, enoxaparin triggers heparin-induced thrombocytopenia (HIT), an immune reaction in which platelet counts fall and, paradoxically, new clots can form. This is one reason platelet counts are checked during treatment.
Enoxaparin carries a boxed warning, the US Food and Drug Administration's most prominent label warning, about spinal and epidural procedures. If a person on enoxaparin has spinal or epidural anesthesia, an epidural pain catheter, or a spinal tap, a bleed can form around the spinal cord and cause long-term or permanent paralysis. The anesthesia team plans the timing of doses around these procedures. After one, back pain, numbness or tingling in the legs, leg weakness, or new trouble controlling the bladder or bowels needs emergency medical attention right away. Other medicines that affect clotting raise the risk of bleeding. These include other blood thinners, aspirin, antiplatelet drugs such as clopidogrel, and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen. Check with the care team before taking an over-the-counter pain reliever, and tell surgeons and dentists about enoxaparin before any procedure. Enoxaparin is not used by people with active major bleeding, by people who have had heparin-induced thrombocytopenia in the past 100 days or still carry its antibodies, or by people allergic to enoxaparin, heparin or pork products (it is made from pig intestine). Severe kidney disease, older age and low body weight make it build up more, so doses and monitoring are adjusted. In pregnancy, available data do not suggest it raises the risk of birth defects. People who are pregnant or planning pregnancy should still discuss timing around delivery and epidural anesthesia with their team. Pregnant people with a mechanical heart valve are a special case: valve clots have occurred on enoxaparin, so this situation needs specialist dosing and close blood-level monitoring.
Enoxaparin reaches its peak effect about three to five hours after an injection, so protection begins quickly, without the days-long build-up warfarin needs. Most people do not feel anything from the medicine itself apart from the injections, which tend to become easier with practice. Because doses are predictable, most people do not need routine clotting tests. The care team usually checks a blood count and platelets, and kidney function when relevant. In some situations, such as pregnancy with a mechanical heart valve, severe kidney disease or very high or low body weight, they may measure an anti-factor Xa level, a blood test that shows how much enoxaparin is active. How long treatment lasts depends on why it was started. Many people use it for a set period after surgery or a hospital stay, while others use it until an oral blood thinner is working or through a pregnancy and after delivery, as the team advises. Stopping early can leave someone unprotected while clot risk is still high, so finish the planned course unless the care team changes it.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Lovenox (Enoxaparin), what you've noticed, or ask the community a question.